What to know before choosing Maximus
Maximus offers some of the clearest GLP-1 pricing documentation in this category. The tradeoff is that its best rates are not flexible monthly prices. They are effective monthly costs on prepaid commitments, and committed plans remain payable even if you stop treatment early.
The FDA warning deserves equal weight. FDA said Maximus used claims that implied its compounded products had been evaluated for safety and effectiveness and described compounding facilities in a way FDA considers false and misleading. Current shoppers should rely on the actual prescription, pharmacy information, and clinician guidance, not broad efficacy language.
Availability and lab requirements can change the practical fit. The current state list excludes or pauses service in several states, while baseline or follow-up tests can be required and billed separately. Confirm both before choosing a long prepaid term.
- Ongoing month-to-month compounded pricing is $249.99 for semaglutide and $359.99 for tirzepatide.
- Prepaid plans lower the effective monthly cost but cannot be ended early for a prorated refund.
- FDA warned Maximus over misleading claims about compounded drugs and compounding facilities.






